Foster Group
PFE icon

Foster Group’s Pfizer PFE Stock Holding History

Foster Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$898K Sell
31,503
-169
-0.5% -$4.5K 0.02% 126
2026
Q2 		$763K Sell
31,672
-820
-3% -$21.4K 0.02% 147
2026
Q1 		$912K Buy
32,492
+958
+3% +$25.5K 0.03% 118
2025
Q4 		$785K Buy
31,534
+319
+1% +$8.04K 0.02% 124
2025
Q3 		$795K Sell
31,215
-194
-0.6% -$4.79K 0.03% 122
2025
Q2 		$761K Buy
31,409
+3,540
+13% +$82.6K 0.03% 117
2025
Q1 		$706K Buy
27,869
+780
+3% +$20.4K 0.03% 106
2024
Q4 		$719K Sell
27,089
-3,026
-10% -$82.1K 0.03% 102
2024
Q3 		$872K Buy
30,115
+1,088
+4% +$31.7K 0.03% 97
2024
Q2 		$812K Sell
29,027
-637
-2% -$17.5K 0.03% 98
2024
Q1 		$823K Buy
29,664
+10,025
+51% +$278K 0.04% 91
2023
Q4 		$651K Hold
19,639
– – 0.04% 90
2023
Q3 		$651K Sell
19,639
-3,665
-16% -$130K 0.04% 90
2023
Q2 		$855K Buy
23,304
+4,485
+24% +$175K 0.05% 82
2023
Q1 		$768K Buy
18,819
+212
+1% +$9.16K 0.05% 85
2022
Q4 		$953K Sell
18,607
-94
-0.5% -$4.51K 0.07% 68
2022
Q3 		$818K Buy
18,701
+356
+2% +$17.3K 0.07% 67
2022
Q2 		$962K Buy
18,345
+4,719
+35% +$240K 0.07% 65
2022
Q1 		$705K Sell
13,626
-11
-0.1% -$571 0.06% 77
2021
Q4 		$805K Sell
13,637
-673
-5% -$33.3K 0.07% 67
2021
Q3 		$615K Buy
14,310
+3
+0% +$133 0.06% 79
2021
Q2 		$560K Buy
14,307
+307
+2% +$11.9K 0.06% 81
2021
Q1 		$507K Buy
14,000
+3
+0% +$107 0.08% 72
2020
Q4 		$515K Buy
+13,997
New +$513K 0.1% 56

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Valley Wealth Managers
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

Foster Group's PFE Position: Q3 2026 in Review

Foster Group reduced its Pfizer (PFE) stake by 0.53% in Q3 2026, selling an estimated $4.5K and leaving 31,503 shares worth $898K. The position accounts for 0.02% of the portfolio, ranked #126.

Foster Group first reported a position in PFE in Q4 2020 and has held it in 24 quarters since. The position peaked at $962K in Q2 2022. 495 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Foster Group held 31,503 shares of Pfizer worth $898K as of Q3 2026.
  • Foster Group sold 169 Pfizer shares in Q3 2026, an estimated $4.5K.
  • Pfizer made up 0.02% of Foster Group's portfolio in Q3 2026, its #126 holding.
  • Foster Group first reported a position in Pfizer in Q4 2020 and has held it in 24 quarters since.
  • Foster Group's Pfizer position peaked at $962K in Q2 2022.
  • 495 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.